During the past decade, Dr. Klaus Peter Jayme conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr. Klaus Peter Jayme" are "Subjective Tinnitus" (3 trials). Many other conditions were trialed in "Dr. Klaus Peter Jayme" in a lesser frequency.

Most popular intervention types in "Dr. Klaus Peter Jayme" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Neramexane mesylate" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Klaus Peter Jayme" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dr. Klaus Peter Jayme". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr. Klaus Peter Jayme, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Klaus Peter Jayme, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".